Physician profile
Frank Gerold
NPI 1851607410
$8,881.99
in general payments reported to CMS, 2019-2025
8 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 76% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $575 · 2021: $783 · 2022: $3,122 · 2023: $933 · 2024: $1,082 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,176.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,153.16 | 2019-2025 | Gamma, Pangea, Variax |
| Axogen | $1,129.96 | 2022 | |
| Depuy Synthes Sales INC. | $235.12 | 2019-2022 | |
| Bioventus LLC | $142.89 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $81.85 | 2019 | |
| Linvatec Corporation | $74.96 | 2023 | Biobrace 23mm |
| Sanara Medtech INC. | $36.79 | 2024 | Celleraterx |
| Endo Pharmaceuticals INC. | $27.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Gerold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.